- Home
- ABBV vs ADI Comparison
ABBV vs ADI Comparison
Compare ABBV & ADI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABBV | ADI |
|---|---|---|
| Founded | 2012 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 358.5B | 203.3B |
| IPO Year | 2012 | 1994 |
Fundamental Metrics
Financial Performance| Metric | ABBV | ADI |
|---|---|---|
| Price | $226.76 | $406.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 22 |
| Target Price | $253.71 | ★ $385.45 |
| AVG Volume (30 Days) | 3.9M | ★ 4.0M |
| Earning Date | 04-29-2026 | 05-20-2026 |
| Dividend Yield | ★ 3.39% | 1.13% |
| EPS Growth | N/A | ★ 39.02 |
| EPS | 0.39 | ★ 4.09 |
| Revenue | ★ $61,160,000,000.00 | $6,200,942,000.00 |
| Revenue This Year | $11.87 | $28.41 |
| Revenue Next Year | $8.12 | $10.25 |
| P/E Ratio | $576.21 | ★ $104.85 |
| Revenue Growth | 8.57 | ★ 21.41 |
| 52 Week Low | $181.75 | $218.38 |
| 52 Week High | $244.81 | $439.70 |
Technical Indicators
Market Signals| Indicator | ABBV | ADI |
|---|---|---|
| Relative Strength Index (RSI) | 68.66 | 49.47 |
| Support Level | $220.11 | $381.22 |
| Resistance Level | $231.00 | $408.37 |
| Average True Range (ATR) | 5.00 | 16.26 |
| MACD | 1.35 | -1.55 |
| Stochastic Oscillator | 89.29 | 41.12 |
Price Performance
Historical ComparisonAbout ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
About ADI Analog Devices Inc.
Analog Devices is a leading analog, mixed-signal, and digital-signal processing chipmaker. The firm has a significant market share lead in converter chips, which are used to translate analog signals to digital and vice versa. The company serves tens of thousands of customers; more than half of its chip sales are to industrial and automotive end markets. ADI's chips are also incorporated into wireless infrastructure equipment.